Navigation Links
Hooper Holmes Announces First Quarter 2008 Results
Date:5/9/2008

BASKING RIDGE, N.J., May 9 /PRNewswire-FirstCall/ -- Hooper Holmes, Inc. (Amex: HH), a leading provider of healthcare assessment services, today announced financial results for the first quarter ended March 31, 2008.

For the three months ended March 31, 2008, total revenues decreased 5.3% to $59.1 million compared to $62.4 million in the first quarter of 2007. The Company recorded a net loss of $0.6 million for the first quarter of 2008, or $(0.01) per share compared to a net loss of $1.7 million, or $(0.02) per share in 2007. The first quarter 2008 results include a loss from continuing operations of $0.6 million, or $(0.01) per share compared to a loss from continuing operations of $1.6 million, or $(0.02) per share in the prior year. The first quarter 2008 loss includes restructuring and other charges of $1.7 million, while the first quarter loss for 2007 included restructuring and other charges of $0.5 million.

First Quarter 2008 Results by Division

Health Information Division (HID)

The Company's Health Information Division reported revenues of $52.4 million for the three months ended March 31, 2008 compared to $54.5 million in the prior year period.

-- Portamedic revenues decreased approximately 6.1% to $36.5 million,

compared to $38.9 million in the first quarter of 2007. This decrease

is the result of a reduction in paramedical exams of approximately 11%

in comparison to the corresponding period of 2007, partially offset by

higher average revenue per exam of 6% due to increased pricing.

-- Infolink revenues were $6.6 million, down 4.2% from $6.9 million in the

first quarter of 2007, primarily due to a decrease in the number of

atten
'/>"/>

SOURCE Hooper Holmes, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine news :

1. Hooper Holmes Names Roy Bubbs President and CEO, Benjamin Currier Continues as Chairman
2. Hooper Holmes Announces Fourth Quarter Earnings Release Date and Conference Call Information
3. Hooper Holmes to Provide Business Update
4. Hooper Holmes Updates Guidance
5. Hooper Holmes Marks 50,000 Health and Wellness Screenings
6. Hooper Holmes Announces Third Quarter 2007 Results
7. Hooper Holmes Appoints Leslie Hudson, PhD, to Board of Directors
8. Hooper Holmes Announces Third Quarter Earnings Release Date and Conference Call Information
9. Hooper Holmes Introduces Mature Assessment
10. Hooper Holmes to Exhibit at the 2007 Sixth Annual Association of Home Office Underwriters Conference
11. Hooper Holmes Concludes Sale of Medicals Direct
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Boston Scientific Announces Pricing of $2 Billion of Senior Notes 2Boston Scientific Announces Pricing of $2 Billion of Senior Notes 3RetireSafe Announces Intention to Key Vote Senator Dorgan's Drug Importation Amendment (SA 2793) 2Hand Surgeons Take Ethics into Their Own Hands 2Hand Surgeons Take Ethics into Their Own Hands 3Hand Surgeons Take Ethics into Their Own Hands 411 More Children Die From Swine Flu 3A CDC 59676 111 More Children Die From Swine Flu 3A CDC 59676 211 More Children Die From Swine Flu 3A CDC 59676 3President Barack Obama Joins President George H W Bush to Celebrate the 20th Anniversary of the Points of Light Volunteer Movement and Extend the Cal 59671 1President Barack Obama Joins President George H W Bush to Celebrate the 20th Anniversary of the Points of Light Volunteer Movement and Extend the Cal 59671 2President Barack Obama Joins President George H W Bush to Celebrate the 20th Anniversary of the Points of Light Volunteer Movement and Extend the Cal 59671 3President Barack Obama Joins President George H W Bush to Celebrate the 20th Anniversary of the Points of Light Volunteer Movement and Extend the Cal 59671 4President Barack Obama Joins President George H W Bush to Celebrate the 20th Anniversary of the Points of Light Volunteer Movement and Extend the Cal 59671 5President Barack Obama Joins President George H W Bush to Celebrate the 20th Anniversary of the Points of Light Volunteer Movement and Extend the Cal 59671 6Peregrine Pharmaceuticals Announces Implementation of 1 3A5 Reverse Stock Split to Take Effect October 19 2009 59666 1Peregrine Pharmaceuticals Announces Implementation of 1 3A5 Reverse Stock Split to Take Effect October 19 2009 59666 2Peregrine Pharmaceuticals Announces Implementation of 1 3A5 Reverse Stock Split to Take Effect October 19 2009 59666 3Peregrine Pharmaceuticals Announces Implementation of 1 3A5 Reverse Stock Split to Take Effect October 19 2009 59666 4
Other Medicine Technology:Sunesis Pharmaceuticals Reports Positive Data From Studies of Two,Anti-Cancer Agents, SNS-595 and SNS-032, at the 12th Congress of,the European Hematology Association 2Sunesis Pharmaceuticals Reports Positive Data From Studies of Two,Anti-Cancer Agents, SNS-595 and SNS-032, at the 12th Congress of,the European Hematology Association 3Sunesis Pharmaceuticals Reports Positive Data From Studies of Two,Anti-Cancer Agents, SNS-595 and SNS-032, at the 12th Congress of,the European Hematology Association 4Sunesis Pharmaceuticals Reports Positive Data From Studies of Two,Anti-Cancer Agents, SNS-595 and SNS-032, at the 12th Congress of,the European Hematology Association 5Sunesis Pharmaceuticals Reports Positive Data From Studies of Two,Anti-Cancer Agents, SNS-595 and SNS-032, at the 12th Congress of,the European Hematology Association 6Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 2Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 3Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 4Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 5Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 6Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 7